Redhawk Wealth Advisors, Inc. Corcept Therapeutics Inc Transaction History

Redhawk Wealth Advisors, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 09, 2019	SELL	$9.78 - $12.76 $235,942 - $307,835	-24,125 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$11.29 - $17.19 $62,433 - $95,060	5,530 Added 29.74%	24,125 $275,000
Q3 2018 Nov 15, 2018	BUY	$12.27 - $15.65 $228,160 - $291,011	18,595 New	18,595 $261,000

355

86.2M

1.12M

667K

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $7.17B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

Get notified when there are updates to the investment portfolio of Redhawk Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Redhawk Wealth Advisors, Inc. with notifications on news.